Sunresin New Materials Co (300487) Q4 2025 earnings summary

Executive summary

• Revenue reached ¥2.79 billion, up 9.08% year-over-year; net profit attributable to shareholders was ¥897 million, up 13.96% year-over-year; gross margin remained above 50% for the third consecutive year.

• Core business segments—life sciences, metal resources, and ultrapure water—drove growth, with life sciences up 12%, metal resources up 23%, and ultrapure water up 9% year-over-year.

• International sales accounted for 22.69% of revenue, with overseas sales of ¥632 million, down 3.52% year-over-year due to trade restrictions.

• R&D investment reached ¥150 million, with 422 R&D staff, and 11 new patents granted (6 domestic, 5 international).

Financial highlights

• Operating cash flow was ¥785 million, up 7.33% year-over-year.

• Total assets at year-end were ¥6.60 billion, up 8.40%; net assets attributable to shareholders were ¥4.39 billion, up 12.13%.

• Basic and diluted EPS were both ¥1.77, up 13.46% and 14.19% respectively.

• Gross margin was 51.46%, with core material products at 54.22%.

• Asset-liability ratio decreased to 33.18% from 35.47% year-over-year.

Outlook and guidance

• Focus on expanding core business in life sciences, ultrapure water, and metal resources, with new capacity coming online in 2026.

• Emphasis on digitalization, intelligent manufacturing, and AI-driven innovation.

• Continued internationalization, with new subsidiaries and local teams in Europe and North America.

• Planned cash dividend of ¥1.73 per 10 shares, totaling ¥179 million, representing 20% of annual net profit.